Drug repurposing for COVID-19: a potential threat of self-medication and controlling measures
-
Published:2020-08-26
Issue:
Volume:
Page:postgradmedj-2020-138447
-
ISSN:0032-5473
-
Container-title:Postgraduate Medical Journal
-
language:en
-
Short-container-title:Postgrad Med J
Author:
Mallhi Tauqeer HussainORCID,
Khan Yusra HabibORCID,
Alotaibi Nasser Hadal,
Alzarea Abdulaziz Ibrahim,
Alanazi Abdullah Salah,
Qasim Sumera,
Iqbal Muhammad Shahid,
Tanveer Nida
Reference11 articles.
1. AlAkhras A , AlMessabi AH , Abuzeid H , et al. Use of specific antimicrobials for COVID-19: should we prescribe them now or wait for more evidence?: the fellowship of postgraduate medicine; 2020.
2. Sanders JM , Monogue ML , Jodlowski TZ , Cutrell JB . Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review. Jama. 2020 May 12;323(18):1824–36.
3. Ferner RE , Aronson JK . Chloroquine and hydroxychloroquine in covid-19. Br Med J Pub Group 2020;m1432. doi: 10.1136/bmj.m1432
4. Caly L , Druce JD , Catton MG , et al. The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antiviral Res 2020:104787.
5. Andreani J , Le Bideau M , Duflot I , et al. In vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect. Microbial pathogenesis 2020:104787.
Cited by
35 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献